Dealing Room Buzz: Eternal, Pidilite, Piramal Pharma, Adani Energy, Coforge, IIFL Finance
This edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Eternal, Pidilite, Piramal Pharma, Adani Energy, Coforge and IIFL Finance.

NDTV Profit India has been tracking the action in the top dealing rooms of India’s financial capital, and this edition of ‘Heard On The Street’ provides you with buzzing action on stocks like Eternal, Pidilite, Piramal Pharma, Adani Energy, Coforge and IIFL Finance.
Heard On The Street provides readers with what well-informed investors, especially HNIs, FIIs, DIIs, and mutual funds, are buying and selling in the stock market. It also tracks the latest unconfirmed/unverified chatter around stocks and/or sectors.
NDTV Profit picked up the following cues from the dealing room chatter during trade:
Eternal
Dealers indicate block deal soon. Antfin, which owns close to 2.1% stake, might look to sell its entire stake
Pidilite
Dealers indicate that there are buy flows on the institutional desk in trade today at lower levels.
Piramal Pharma
The stock is down in trade on the anticipation of a block deal that is expected soon.
Adani Energy
The stock has recovered from its day’s lowest point as dealers indicate buy flows on the domestic institutional investor desk.
Coforge
The stock has been a top loser in the Nifty IT index, as a large prominent foreign institutional investor is a seller in Coforge.
IIFL Finance
The stock is gaining in trade today as the street is anticipating a big management rejig. Dealers indicate that a prominent industry name who resigned from an NBFC is set to join soon.
Disclaimer:- The mentioned stocks capture NDTV Profit's dealing room channel checks during trading hours. The information provided is for informational purposes. However, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, or suitability of the information. This content does not constitute financial, investment, or trading advice and should not be construed as a recommendation to buy, sell, or hold any securities.